Search Results 821-830 of 17552 for treatment resistant depression
A Study Of Single Patient Investigational Drug CPI-613 For Use In Treatment-Refractory, Metastatic Prostate Cancer. Print details. Share; Facebook · Twitter.
Mayo Clinic psychiatrists and psychologists are leaders in the clinical care of mental illnesses in people of all ages. They tailor their care to your exact ...
Do zinc supplements shorten colds? Natural remedies for depression: Are they effective? Share · Tweet. Sept. 26, 2024.
Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care featured · Mayo Clinic discovery of breast cancer treatment resistance ...
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia. Rochester, Minn. This phase I trial evaluates the safety, ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
This will be done by looking at the pharmacokinetics of MT-0169after a single dose and after repeat doses in people with relapsed or refractory multiple myeloma ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. Turkey Tail ...
August 2, 2023. 2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image. Research. 2023 Gerstner Awardee's ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!